Manufacture and Supply of Infant Endotracheal Tubes (ET Tubes)

The contract requires the full manufacturing, quality control, packaging, and delivery of infant endotracheal tubes that meet stringent regulatory standards including FDA 21 CFR 868.5730, 510(k) clearance, current good manufacturing practices, and proper labeling requirements. All products must be produced in compliance with federal medical device regulations to ensure safety, efficacy, and consistency for use in neonatal and infant critical care settings. The manufacturing process must include rigorous in-process and final quality inspections, validated packaging protocols to maintain sterility, and end-to-end traceability to support regulatory audits and clinical use. This is a subcontract under the Department of Defense’s Medical Supply Chain, specifically managed by the MD SURG FSF office, with performance taking place at the APO ZIP code 96264-2022. The solicitation, identified by the reference SPE2DS26T312F, was posted on August 5, 2026, with responses due by August 11, 2026. The NAICS code 325620 indicates the work falls under Plastic Product Manufacturing, specifically for medical devices. All submitted bids must demonstrate proven capability in producing infant endotracheal tubes under cGMP, with documentation supporting compliance with FDA requirements and the ability to deliver quantities sufficient for federal medical supply chain needs.